B2DB — Who said what, where, and when

Benjamien Moeyaert

Co-founder | Platform lead, Tavira Therapeutics

Tavira Therapeutics, founded in 2023, develops advanced AAV gene-delivery technologies. Its proprietary capsid engineering platform enables enhanced tissue targeting, led by a best-in-class capsid designed for efficient CNS delivery.

Events Benjamien Moeyaert has spoken at